|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
ABSTRACT |
|---|
|
|
|---|
Most exhaled water is produced as gaseous water vapor, which
can be collected in cooled condensers. The presence of nonvolatile solutes in these condensates suggests that droplets of respiratory fluid (RF) have also been collected. However, calculation of RF solute
concentrations from condensates requires estimation of the dilution of RF droplets by water vapor. We used condensate electrolyte
concentrations to calculate the dilution of RF droplets in condensates from 20 normal subjects. The total ionic concentration (conductivity) was 497 ± 68 (mean ± SEM) µM. Of this, 229 ± 43 µM was
NH4+, but little NH4+ was collected from subjects with tracheostomies, indicating oral formation. The Na+ concentration in condensate
([Na+]cond) averaged 242 ± 43 µM. Large variations in [Na+]cond
correlated well with variations of K+ in condensate ([K+]cond) and Cl
in condensate ([Cl
]cond), and were attributed to differences in respiratory droplet dilution. Dividing condensate values of ([Na+] + [K+] ) by those of plasma indicated that RF represented between
0.01% and 2.00% of condensate volumes. Calculated values for
Na+, K+, Cl
, lactate, and protein in RF were [Na+]RF = 91 ± 8 mM,
[K+]RF = 60 ± 11 mM, [Cl
]RF = 102 ± 17 mM, [lactate]RF = 44 ± 17 mM, and [protein]RF = 7.63 ± 1.82 g/dl, respectively.
| |
INTRODUCTION |
|---|
|
|
|---|
Keywords: exhaled condensates; respiratory secretions; aerosol droplets; saliva; bronchoalveolar lavage
Bronchoalveolar lavage (BAL) has improved understanding of the pathogenesis of inflammatory lung diseases and has been helpful in detecting and distinguishing these disorders. Performance of BAL is associated with some risk, including impairment of gas exchange and pneumonitis, and it is difficult to repeat BAL at frequent intervals. It would be preferable if the presence of inflammation in the lungs could be noninvasively followed in exhaled air. More than 200 volatile substances have been detected in exhaled air (1), including NO, which has been used to assess pulmonary inflammation in asthma (2). Unfortunately, most inflammatory mediators and other solutes of interest are not volatile and are consequently not present in the gaseous phase of exhaled air. Nevertheless, low concentrations of these solutes have been found in exhaled water collected with cooled condensers. These solutes are presumably present in droplets released from the fluid lining the respiratory membranes. Increased concentrations of inflammatory markers have been reported in the exhaled condensate collected from patients with a variety of pulmonary disorders (Table 1) (3).
|
We investigated the electrolyte and buffer concentrations
of solutes present in the exhaled condensate of normal subjects. The concentrations of these solutes were much lower
than those in plasma, ranging from less than 0.01% to as much
as 2% of those in plasma. Marked variations in solute concentrations were found among normal subjects and in individual
subjects between tests. Similar variability in solute recovery
was reported by Scheideler and coworkers (24), who were unable to detect any protein in the condensates of two normal
subjects and found protein concentrations between 0.76 µg/ml
and 107.7 µg/ml in condensate from eight other healthy individuals. We also found that condensate concentrations of Na+,
K+, and Cl
were well correlated with one another over a 200-fold range of concentrations. This observation suggests that
dilution of droplets generated in the respiratory tree by water
vapor varies considerably. It is consequently impossible to determine whether increases in the concentrations of mediators
reported in various disorders reflect increased droplet formation or increases in the concentrations of these mediators in
fluid lining the respiratory tract.
All of the nonvolatile solutes in respiratory droplets should be diluted to the same degree by water vapor deposited on the walls of the condenser. We minimized the effect of dilution by dividing condensate solute concentrations by the sum of the concentrations of the principal nonvolatile cations ([Na+] + [K+]) in the condensate. Furthermore, by assuming that respiratory secretions are isosmotic with plasma, we were able to estimate the actual dilution of the respiratory solutes in the condensate and the concentrations of the solutes in the respiratory fluids (RFs).
In the course of these studies, we found that there are significant amounts of NH4+ in exhaled condensate. Most of this appears to be generated in the mouth, and the efficiency with which NH4+ is collected in the condenser is influenced by such factors as the configuration of the collection tubing and the partial pressure of CO2 (PCO2) in the air traversing the condenser. In addition, we observed significant concentrations of lactate, which seemed to be derived from the lungs, in condensate. These two ions appear to have been the principal buffers that were collected, and they may influence the pH of two exhaled condensate. This may be clinically relevant, since it has been reported that the pH of condensate is acidic in patients with exacerbations of asthma (3).
| |
METHODS |
|---|
|
|
|---|
Subjects
Twenty subjects (14 males and six females), without histories of pulmonary disease or recent smoking, were studied. The average age was 31.6 yr (range: 22 to 53 yr). Condensates were also collected from three subjects with chronic tracheostomies for obstructive sleep apnea.
Procedures
Subjects exhaled into a glass condenser cooled with circulating ice water for approximately 1 h, until about 10 ml of condensate were collected. Approximately 2 ml of saliva were also collected. Samples
were stored in Falcon Blue Max polypropylene centrifuge tubes (Becton-Dickinson, Franklin Lakes, NJ) at
20° C.
We determined the effect of the length of the collector tubing on the collection of NH4+ and Na+ by comparing condensates from a single normal subject: five condensate samples were collected with the standard tubing (64 cm long × 22 mm I.D.; Corr-a-Flex 2, Hudson RCI, Temecula, CA) and five samples were collected when the tubing had been reduced to 16 cm in length.
An additional study was conducted to determine the effect of CO2 on the efficiency of NH4+ collection by the condenser. A dog ventilator was connected to a clinical humidifier that was filled with an isotonic saline solution containing 2 mM NH4Cl. Room air was pumped at 5 L/min (250 ml per stroke × 20 strokes/min) over the fluid in the humidifier without bubbling. The fluid was kept at a sufficiently high temperature (84° C) to maintain the temperature entering the condenser tubing at 37° C and the humidity at 100%. In six experiments, the air pumped into the condenser contained 6% CO2, and in six other studies it contained no CO2. The humidifier solution was buffered at pH 7.4 with 25 mM NaHCO3 in the CO2 experiments, and with 12 mM 4-(2-hydroxyethyl)-1-piperazine-N-2-ethanesulfonic acid in the air experiments.
Chemical Analyses
Amylase was measured with a modification of a kit (577) from Sigma (St. Louis, MO), lactate oxidase with another kit (735-10) from Sigma, and lactic dehydrogenase with a third Sigma kit (826B). The Protein Micro BCA protein assay reagent kit (Pierce, Rockford, IL) was used to measure protein with the bicinchoninic acid method. Nitrate and nitrite were quantitated through a modified Griess reaction. Coefficients of variation (CV) of conductivity, electrolytes, and NH4+ are shown in Table 2.
|
Calculations
The dilution (D) of respiratory droplets by water vapor in the condensate was calculated with the equation:
|
(1) |
In this group of normal subjects, it was assumed that [Na+]plasma + [K+]plasma = 144 mM. Concentrations of solutes ([X]RF) in RF were calculated from the product of their concentration in the condensate and the dilution:
|
(2) |
Statistical Analysis
Friedman's repeated-measures analysis of variance (ANOVA) on ranks, with the Student-Newman-Keul's method of comparing pairs of values, were used to analyze the condensate data (SigmaStat 2; Jandel Scientific, San Rafael, CA), and a value of p < 0.05 was considered significant. One-way ANOVA with Tukey's test was used to analyze saliva data. Linear regression and correlation coefficients were calculated with the same program.
Studies of human subjects were approved by the Human Research Review Committee of the Zablocki VA Hospital and the Medical College of Wisconsin.
| |
RESULTS |
|---|
|
|
|---|
Electrolytes
As indicated in Figure 1, the average conductivity of the condensate was equivalent to 497 ± 34 (mean ± SEM) µM NaCl.
Ammonium represented a significant fraction of the cations
collected ([NH4+]cond = 229 ± 49 µM, Na+ = 242 ± 140 µM, and
K+ = 80 ± 36 µM). Chloride concentrations averaged 231 ± 109 µM, and lactate averaged 393 ± 305 µM. (Only six samples
were analyzed for lactate and eight samples were analyzed for
protein. To avoid misinterpretation related to differences in
sample sizes, we chose not to include the lactate and protein
data in the histogram shown in Figure 1.) Values of conductivity were significantly greater (p < 0.05, as judged with a repeated measures, nonparametric test) than those of NH4+,
Na+, K+, and Cl
. Concentrations of NH4+ were significantly
greater than those of K+, Cl
, and Na+ by the same criteria.
Differences between mean values and median values (indicated
by filled circles in Figure 1) were due to variability in the data.
|
Variability was seen among subjects, but it was also observed in samples from four subjects collected at different
times over the course of several days (Figure 2). We were unable to find any cause for this variation, but good correlations
were found between concentrations of Na+, Cl
, and K+ (Figure 3, upper two panels). The variability of the data was reduced when the concentrations of solutes were divided by the sum of the Na+ and K+ concentrations (note that the mean
and median values are similar and that standard errors are relatively small in the first four bars in the histogram shown in
Figure 4). NH4+ concentrations in the condensate were poorly
coordinated with those of Na+ (Figure 3, bottom panel ).
|
|
|
Total concentrations of the measured nonvolatile cations
were approximately the same as those of anions: the sum of
the lactate and Cl
concentrations equaled that of the Na+
and K+ concentrations (Figure 4, fifth bar of the histogram).
Furthermore, most of the conductivity could be accounted for
by the measured cations (and their associated anions): the sum
of the NH4+, Na+, and K+ (with associated anions) concentrations accounted for virtually all of the observed conductivity
(Figure 4, sixth bar of the histogram). If it is assumed that the
normal sum of the plasma Na+ and K+ concentrations is 144 mM,
then the dilution of RF by the water vapor collected in the
condenser averaged 1:2,443 ± 453.
Using Equation 2, we calculated values for the concentrations of ions and protein in RF. These were [Na+]RF = 91 ± 8 mM, [K+]RF = 60 ± 11 mM, [Cl
]RF = 102 ± 17 mM, [lactate]RF = 44 ± 17 mM, and [protein]RF = 7.63 ± 1.82 g/dl.
Concentrations of NH4+ in the condensate averaged 229 ± 43 µM for normal subjects, but no NH4+ was detectable in the condensates collected from tracheostomies in three subjects with obstructive sleep apnea. Na+ concentrations in the condensates of these individuals ranged from 25 to 1,385 µM, and lactate concentrations ranged from 0 to 85 µM. Recovery of NH4+ in the exhaled condensate was enhanced by decreasing the dead space between the mouthpiece and the condenser by 75% (Figure 5). This did not have any effect on the recovery of Na+. Incoproration of 6% CO2 in air pumped through the condenser also increased the recovery of NH4+ (Figure 6).
|
|
Concentrations of both NO2
and NO3
were comparatively very small as compared with those of the other measured ions (NO2
= 0.76 ± 0.14 µM, n = 14; NO3
= 4.3 ± 1.0 µM, n = 15). Amylase was undetectable in the condensates of
five of the subjects and was present in very low concentrations in the condensates of the others; with a mean concentration of 4.67 units/ml, or less than 2 × 10
5 that in the saliva. Protein
concentrations averaged 2.3 mg/dl, or 1.2 × 10
3 of the concentrations in the saliva.
As indicated in Figure 7, salivary solute concentrations were
much greater than condensate concentrations for all measured solutes (note that concentrations of the electrolytes are indicated in units of mM rather than µM). Concentrations of K+ and Cl
were significantly greater than those of Na+, NH4+, and lactate.
|
| |
DISCUSSION |
|---|
|
|
|---|
The saturation of exhaled air with water normally exceeds 90%, and the rate of water loss by this route is largely governed by the rate of ventilation. Most of the water lost from the lungs is formed as water vapor, a gas that does not contain nonvolatile solutes. As indicated in Figure 8, the only way that nonvolatile solutes can be lost from the surface of the lungs is in the form of respiratory droplets. Droplets formed in this fashion can be deposited on the walls of a condenser, but most of the water that accumulates on the condenser surfaces is derived from water vapor rather than from droplets generated from the secretions lining the pulmonary surfaces. Within condensate samples, the dilution by water vapor of the solute concentrations in respiratory droplets can be estimated from the concentrations of nonvolatile constituents in the condensate.
|
Nonvolatile Solutes
Despite considerable variation in normal electrolyte concentrations in condensates of respiratory exhalations, we found
good correlations between condensate concentrations of Na+,
K+, and Cl
. This observation is consistent with the proposition that dilution of respiratory droplets by water vapor deposited in the condensate results in equivalent dilution of each of
these electrolytes. Our calculation of the dilution of respiratory
droplets was based on two assumptions. The first of these was
that respiratory secretions have the same osmolality as plasma.
This premise is supported by the observation by Jayaraman
and coworkers (25) that the fluids lining cultures of tracheal
epithelial cells, live mouse tracheas, and freshly harvested human bronchi are isosmotic. The second assumption in our calculation was that the sum of the Na+ and K+ concentrations in
the RFs is equal to that in the plasma. This postulate is justified
by these electrolytes and associated anions being the principal
solutes in plasma and cellular fluid, and by the observation that
they appear to represent the principal nonvolatile, respiratory
cations in respiratory condensate. The dilution of RF by condensate averaged 1:2443. It can therefore be concluded that of
the 500 ml of water exhaled in a 24-h period, only 200 µl of RF
is lost in the form of droplets each day by normal subjects.
On the assumption that the sum of the plasma Na+ and K+
concentrations is 144 mM, the following values were calculated from Equation 2 for these ions in the RF: [Na+]RF = 91 ± 8 (mean ± SEM) mM, [K+]RF = 60 ± 11 mM, and
[Cl
]RF = 102 ± 17 mM. In the study by Jayaraman and colleagues (25), human bronchi were covered with a layer of fluid
which was 55 ± 5 µm thick and contained [Na+] = 103 ± 3 mM and [Cl
] = 92 ± 4 mM. This would represent a somewhat hypotonic fluid, but Jayaraman and colleagues were unable to measure [K+], which averaged about 60% of [Na+] in
the present study of exhaled condensates. K+ concentrations
in plasma are much lower than this (approximately 4% of Na+
concentrations), but are greater than in plasma in both BAL
fluid collected from animals (26) and in the fluid secreted by
fetal animals (27).
Lactate concentrations in the condensate were 32% of the sum of the Na+ and K+ concentrations. This is considerably greater than in plasma, in which lactate concentrations are less than 1% of the sum of the Na+ and K+ concentrations. It has been noted that much of the glucose metabolized by the lungs is converted to lactate rather than to CO2 despite high ambient oxygen concentrations in lung tissues (28). This may reflect a relative deficiency of mitochondria in regions with attenuated numbers of pulmonary alveolar type I cells. Concentrations of K+ in saliva were significantly higher than those of Na+ in the study just cited (28), as well as in other studies (29, 30).
The conductivity of the condensate was expressed in terms
of micromoles per liter of NaCl. The sum of [Na+], [K+], and
[NH4+] (and their associated anions) accounted for virtually
all of the conductivity in these studies. The sum of the Cl
and
lactate concentrations was approximately the same as that of
the Na+ and K+ concentrations (Figure 4, fourth bar in the histogram). These four ions appear to be the principal stable ions
in respiratory condensate. Smaller concentrations of nitrate
and nitrite were also found. These were comparable to those
reported by Hunt and associates (21).
Concentrations of amylase in the condensates from normal subjects were frequently undetectable and were disproportionately lower than those in saliva. The average amylase concentration in the condensate was less than 0.01% of that in saliva. In contrast, the condensate Na+ concentration averaged 32% of that in saliva. These observations indicate that relatively few of the droplets captured in condensate were formed in the mouth and most presumably came from elsewhere in the respiratory tract. Filtration of exhaled air (e.g., as in the study by Hunt and colleagues [3]) is therefore not needed to remove oral fluids from the condensates of normal subjects. Filtration might actually decrease the efficiency of collection of respiratory secretions in condensate samples, and there is no evidence that a filter with a specific pore size would selectively remove droplets produced in the mouth.
The calculated values of protein in RF were variable but quite high (7.29 ± 4.29 g/dl), approximating those in plasma.
Ammonium
Concentrations of NH4+ (229 ± 43 µM) in condensate exceeded those of Na+ and K+ and were significantly greater than that found in blood (normally between 6 µM and 47 µM) (31). Since no NH4+ was detectable in the exhaled condensates collected from patients with tracheostomies, it appears that most of the NH4+ in condensate is actually formed in the mouth. Oral NH4+ is generated in part by bacterial hydrolysis of urea in the oral cavity (32), but secretion of NH4+ by salivary and respiratory glands is possible. Normal concentrations of NH3 in exhaled air are very variable, ranging between 0.1 ppb and 100 ppb, and are not closely linked to blood ammonia levels. For example, breath NH3 levels in uremic subjects were from five to 20 times greater than normal, even though blood ammonia levels were well within normal range (38). Much of the exhaled NH3 is actually formed in the mouth. Concentrations of NH4+ in saliva averaged 1,189 µM in the present study and 2,500 µM in another report (41).
We found three reasons for concluding that most of the NH4+ trapped within the condenser in our study was delivered there as NH3 gas rather than as NH4+ dissolved in droplets. The first reason for this was the observation that increasing the PCO2 of air from 0 to 6% increased the concentrations of NH4+ captured in the condensate (Figure 6). This can be explained by more efficient trapping of NH3 gas as NH4+ by acidic droplets (Figure 9) (42). For example, if the concentration of NH3 is the same on the respiratory or oral membranes, m, where it is generated, and in the condenser, then
|
(3) |
|
(4) |
|
where Ka designates the acid dissociation constant of NH4+ (Ka = 9.25).
Thus, if the pH of the droplets in the condenser is 1 unit less than in the fluids lining the respiratory membranes, then once an equilibrium is reached, the concentrations of NH4+ in the condenser droplets should become 10 times greater than those on the respiratory membranes, where the NH4+ was formed. Concentrations of CO2 in the condenser and droplets at the end of exhalation should reach about 1,250 µM (equivalent to 40 mm Hg). Because this is much greater than the concentrations of NH3, or of any other buffer in the condensate, the pH of the droplets in the condenser is presumably governed by the PCO2 of the expired air. At a normal PCO2 of 40 mm Hg, the pH of an unbuffered aqueous solution is below 6 (43), and efficient "trapping" of NH4+ in the condensate would therefore be expected.
The second reason for concluding that NH4+ trapped in the condenser was delivered in the form of NH3 gas is the effect of tubing length on concentrations of NH4+ found in the condensate (Figure 5). NH4+ concentrations in the condensate were greater when the length of the tubing between the mouthpiece and condenser was reduced. This presumably reflects some trapping in the small amount of fluid that remains on the surfaces of this tubing. Concentrations of Na+ in the condensate were not influenced by this change because Na+ was delivered proportionately with water droplets throughout the tubing and condenser.
The third reason for proposing that NH4+ collected in the condensate was delivered as a gas rather than in droplets was the observation that, although concentrations of electrolytes were well correlated with one another, correlations between Na+ and NH4+ concentrations in the condensate were very poor (Figure 3). This indicates that much of the NH4+ in the condensate was not delivered as droplets from the airways.
If it were assumed that most of the NH3 in exhaled air is captured in the condensate, then the amount of NH3 lost each day in the exhalate would amount to about 115 µmol. This represents significantly less than 0.1% of the nitrogen lost as urea in the urine each day (0.5 moles) and less than 0.3% of the amount lost as urine NH4+ (approximately 35 mmol when the urine has a pH of 5.0) (44).
Following collection, the condensate in our studies was exposed to air, and it is likely that most of the CO2 was lost. Hunt and colleagues (3) degassed their samples with argon, a procedure that should have removed virtually all of the CO2. However, removal of NH3 from solutions can only be accomplished if the solutions are initially alkalinized to pH values above 10, and concentrations of NH4+ in both the study by Hunt and colleagues and in the present study were presumably relatively constant after collection (45). The concentration of NH4+ trapped in the condensate will be determined in part by the original PCO2 of the exhaled air. It is therefore possible that the low values of pH found in asthmatic subjects by Hunt and colleagues partly reflect the increased dead space and hyperventilation in asthmatic subjects. These abnormalities of ventilation would decrease the end-tidal PCO2 and the PCO2 in the condensate. This in turn would reduce the amount of NH4+ that was trapped. Once CO2 was purged from the asthmatic samples with argon, the pH of the condensate would be relatively acid because it contained less NH4+. However, it is also possible that the production of NH3 is reduced in asthma or that an acid species, such as lactic acid, is secreted into the airway fluid during asthmatic attacks. Nevertheless, interpretation of condensate pH is complicated by the partial dependency of NH4+ concentrations in the condensate on conditions in the mouth and by the efficiency with which NH3 is trapped in the condenser. It is also complicated by the extremely low concentrations of acids, bases, and buffers found in exhaled water (43, 46).
Concentrations and Concentration Ratios
Much of the variation found in nonvolatile solute concentrations in expiratory condensates is probably related to differences in the dilution of respiratory droplets by the water of vaporization. This is a serious problem, since increases in concentrations of individual mediators may reflect increased droplet formation rather than increases in mediator concentrations in the RF. Increased droplet formation could be associated with clinical evidence for bubbling in the respiratory tree (e.g., rales, wheezes, and rhonchi). It is possible to minimize differences in solute concentrations related to droplet formation by calculating the ratio of relative concentrations of these solutes to the concentration of some other solute. For example, the ratio of oxidized to reduced glutathione may yield useful data concerning redox potentials in tissue. Interpretation of changes in the concentrations of individual indicators in the condensate cannot be reliably made unless the dilution of the RF by exhaled water vapor is known. This dilution can be estimated from the concentrations of one or more reference indicators that are present in similar concentrations in RF and plasma. For reasons described previously, we have chosen the sum of the Na+ and K+ concentrations for this purpose. Other indicators, such as urea, might be used instead, since concentrations of urea tend to be similar in most body compartments. Unfortunately, it is difficult to measure small concentrations of urea in exhalate, in part because of the presence of high concentrations of ammonia, which is also the product of enzymatic assays of urea.
Similar problems with dilution have been associated with
BAL, since the RF are diluted in the relatively large volume of
lavage fluid, which characteristically consists of saline. One of
the important advantages of the condensate approach is that
the RF on the surface of the lung remains undisturbed and undiluted. This avoids sudden shifts of solutes from the tissues to
airspaces that occur during lavage (26). The condensate approach also makes it possible to measure Na+ and Cl
concentrations, which is not possible when the lungs are lavaged with
saline solutions. However, concentrations of all solutes in exhaled condensates are often extremely low, and measurements of the concentrations of electrolytes and other solutes
may be very difficult to make with sufficient accuracy. This is
illustrated in Table 2, which shows how the reproducibility of
such measurements tends to decrease at low concentrations. It
should be emphasized that even a CV as great as 15% would
represent a considerable improvement over variation related
to droplet dilution, which can be more than 100-fold (i.e.,
104%). Studies of condensates should include similar information about the reproducibility of measurements of the solutes,
including the "reference" indicators.
If the quantity of droplets in exhaled condensate is very low, and concentrations of the reference indicators (e.g., Na+ + K+) cannot be determined in a reliable manner, then interpretation of the concentrations of any other solutes (e.g., inflammatory mediators) becomes problematic. Regardless of the accuracy with which inflammatory mediators can be measured, changes in their concentrations in condensate may vary by a factor of 100 or more, depending on variations in the dilution of respiratory droplets by the water of vaporization. Methods should be developed to increase respiratory droplet production, so that more reliable estimates of solute dilution can be made. In addition, methods for analyzing very low concentrations of reference and other indicators should be pursued.
| |
Footnotes |
|---|
Correspondence and requests for reprints should be addressed to Richard M. Effros, M.D., 9200 West Wisconsin Ave., Milwaukee, WI 53226. E-mail: effros{at}mcw.edu
(Received in original form January 5, 2001 and accepted in revised form November 15, 2001).
Acknowledgments:
Supported by Grants HL60057 and DC03191 from the National Institutes of Health.
| |
References |
|---|
|
|
|---|
1.
Manolis A.
The diagnostic potential of breath analysis.
Clin Chem
1983;
29:
5-15
2. Ashutosh K. Nitric oxide and asthma: a review. Curr Opin Pulm Med 2000; 6: 21-25 . [Medline]
3.
Hunt JF,
Fang K,
Mlik R,
Snyder A,
Malhotra N,
Platts-Mills TAE,
Gaston B.
Endogenous airway acidfication. Implications for asthma
pathophysiology.
Am J Respir Crit Care Med
2000;
161:
694-699
4. Nowak D, Kalucka S, Bialasiewicz P, Krol M. Exhalation of H2O2 and thiobarbituric acid reactive substances (TBARs) by healthy subjects. Free Radic Biol Med 2001; 30: 178-186 [Medline].
5. Antczak A, Kurmanowska Z, Kasielski M, Nowak D. Inhaled glucocorticosteroids decrease hydrogen peroxide level in expired air condensate in asthmatic patients. Respir Med 2000; 94: 416-421 [Medline].
6. Schleiss MB, Hoiz O, Behnke M, Richter K, Magnussen H, Jones RA. The concentration of hydrogen peroxide in exhaled air depends on expiratory flow rate. Eur Respir J 2000; 16: 1115-1118 [Abstract].
7. Antczak A, Nowak D, Bialasiewicz P, Kasielski M. Hydrogen peroxide in expired air condensate correlates positively with early steps of peripheral neutrophil activation in asthmatic patients. Arch Immunol Ther Exp (Warsaw) 1999; 47: 119-126 . [Medline]
8. Guatura SB, Martinez JA, Santos Bueno PC, Santos ML. Increased exhalation of hydrogen peroxide in healthy subjects following cigarette consumption. Sao Paulo Med J 2000;118:93-98.
9. Ho LP, Faccenda I, Innes IA, Greening AP. Expired hydrogen peroxide in breath condensate of cystic fibrosis patients. Eur Respir J 1999; 13: 103-106 [Abstract].
10. Jobsis Q, Raatgeep HC, Schellekens SL, Kroesbergen A, Hop WC, de Jongste JC. Hydrogen peroxide and nitric oxide in exhaled air of children with cystic fibrosis during antibiotic treatment. Eur Respir J 2000; 16: 95-100 [Abstract].
11.
Loukides S,
Horvath I,
Wodehouse T,
Cole PJ,
Barnes PJ.
Elevated levels of expired breath hydrogen peroxide in bronchiectasis.
Am J
Respir Crit Care Med
1998;
158:
991-994
12. Dekhuijzen PN, Aben KK, Dekker I, Aarts LP, Wielders PL, van Hetwaarden CL, Bast A. Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 154: 813-816 [Abstract].
13. De Benedeto F, Aceto A, Dragani B, Spacone A, Formisano S, Cocco R, Sanguinetti CM. Validation of a new technique to assess exhaled hydrogen peroxide: results from normals and COPD patients. Monaldi Arch Chest Dis 2000; 55: 185-188 [Medline].
14. McRae K, De Perrot M, Fischer S, Waddell TK, Liu M, Kesliavjee S. Detection of IL-10 in the exhaled breath condensate, plasma and tissue during ischemia-reperfusion injury in experimental lung transplantation. J Heart Lung Transplant 2001; 20: 184 .
15.
Montuschi P,
Collins JV,
Ciabattoni G,
Lazzeri N,
Corradi M,
Kharitonov SA,
Barnes PJ.
Exhaled 8-isoprostane as an in vivo biomarker
of lung oxidative stress in patients with COPD and healthy smokers.
Am J Respir Crit Care Med
2000;
162:
1175-1177
16.
Montuschi P,
Corradi M,
Ciabattoni G,
Nightingale I,
Kharitonov SA,
Barnes PJ.
Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patients.
Am J Respir Crit Care Med
1999;
160:
216-220
17.
Carpenter CT,
Price PV,
Christman BW.
Exhaled breath condensate
isoprostanes are elevated in patients with acute lung injury or ARDS.
Chest
1998;
114:
1653-1659
18.
Montuschi P,
Collins JV,
Ciabattoni G,
Lazzeri N,
Corradi M,
Kharitonov SA,
Barnes PJ.
Exhaled 8-isoprostane as a new non-invasive biomarker
of oxidative stress in cystic fibrosis.
Thorax
2000;
55:
205-209
19.
Corradi M,
Montuschi P,
Donnelly LE,
Pesci A,
Kharitonov SA,
Barnes PJ.
Increased nitrosothiols in exhaled breath condensate in inflammatory airway diseases.
Am J Respir Crit Care Med
2001;
163:
854-858
20. Reinhold P, Becher G, Rothe M. Evaluation of the measurement of leukotriene B4 concentrations in exhaled condensate as a noninvasive method for assessing mediators of inflammation in the lungs of calves. Am J Vet Res 2000; 61: 742-749 [Medline].
21. Hunt J, Byrns RE, Ignarro LJ, Gaston B. Condensed expirate nitrite as a home marker for acute asthma. Lancet 1995; 346: 1235-1236 [Medline].
22.
Hanazawa T,
Kharitonov SA,
Barnes PI.
Increased nitrotyrosine in exhaled breath condensate of patients with asthma.
Am J Respir Crit
Care Med
2000;
162:
1273-1276
23. Nowak D, Kasielski M, Antczak A, Pietras T, Bialasiewicz P. Increased content of thiobarbituric acid-reactive substances and hydrogen peroxide in the expired breath condensate of patients with stable chronic obstructive pulmonary disease: no significant effect of smoking. Respir Med 1999; 93: 389-396 [Medline].
24. Scheideler L, Manke HG, Schwulera U, Inacker O, Hammerle H. Detection of nonvolatile macromolecules in breath. A possible diagnostic tool? Am Rev Respair Dis 1993; 148: 778-784 .
25. Jayaraman S, Song Y, Vetrivel L, Shankar L, Verkman AS. Noninvasive in vivo fluorescence measurement of airway-surface liquid depth, salt concentration, and pH. J Clin Invest 2001; 107: 317-324 [Medline].
26.
Effros RM,
Feng D,
Mason G,
Sietsema K,
Silverman P,
Hukkanen J.
Solute concentrations of the epithelial lining fluid of anesthetized rats.
J Appl Physiol
1990;
68:
275-281
27.
Adamson TM,
Boyd RDDH,
Platt HS,
Strang LB.
Composition of alveolar liquid in the foetal lamb.
J Physiol (Lond)
1969;
204:
159-168
28. O'Neill JJ, Tierney DF. Rat lung metabolism: glucose utilization by isolated perfused lungs and tissue slices. Am J Physiol 1974; 226: 867-876 .
29. Thaysen JH, Thom NA, Schwartz IL. Excretion of sodium, potassium, chloride and carbon dioxide in human parotid saliva. Am J Physiol 1954; 178: 155-159 .
30. Yavuzyilmaz E, Yumak O, Akdoganli T, Yamalik N, Ozer N, Ersoy F, Yeniay I. The alterations of whole saliva constituents in patients with diabetes mellitus. Austr Dent J 1996; 41: 193-197 .
31. Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DL, Hauser SL, Longo DL, editors. Harrison's principles of internal medicine, 14th edition. New York: McGraw-Hill; 2000. Appendix A2 values of clinical importance.
32.
Jaquez JA,
Popell JW,
Jeltsch R.
Partial pressure of ammonia in alveolar air.
Science
1959;
129:
269-270
33.
Larson TV,
Covert DS,
Frank R,
Charlson RJ.
Ammonia in the human
airways: neutralization of inspired acid sulfate aerosols.
Science
1977;
197:
161-163
34.
Larson TV,
Covert DS,
Frank R.
A method for continuous measurement
of ammonia in respiratory airways.
J Appl Physiol
1979;
46:
603-607
35. Lovett AM, Reid NM, Buckley JA, French JB, Cameron DM. Real time analysis of breath using an atmospheric pressure ionization mass spectrometer. Biomed Mass Spectrom 1979; 6: 91-97 [Medline].
36. Lowenstein JM. The purine nucleotide cycle revised. Int J Sports Med 1990; 11: S37-S46 .
37. Wakabayashi H, Kuwabara Y, Murata H, Kobashi K, Watanabe A. Measurement of the expiratory ammonia concentration and its clinical significance. Metab Brain Dis 1997; 12: 161-169 [Medline].
38. Davies S, Patrik S, Smith D. Quantitative analysis of ammonia on the breath of patients in end-stage renal failure. Kidney Int 1997; 52: 223-228 [Medline].
39. Ament W, Huizenga JR, Kort E, van der Mark TW, Gevink RG, Verkerke GJ. Respiratory ammonia output and blood ammonia concentration during incremental exercise. Int J Sports Med 1999; 20: 71-77 [Medline].
40. Shimamoto C, Ichiro H, Katsu K. Breath and blood ammonia in liver cirrhosis. Hepatogastroenterology 2000; 47: 443-445 [Medline].
41. Huizenga JR, Vissink A, Kuipers EJ, Gips CH. Helicobacter pylori and ammonia concentrations of whole, parotid and submandibular/sublingual saliva. Clin Oral Invest 1999; 3: 84-87 . [Medline]
42. Orloff J, Berliner RW. The mechanism of the excretion of ammonia in the dog. J Clin Invest 1956; 35: 223-235 .
43. Story DA, Thistlethwaite P, Bellomo R. The effect of PVC packaging on the acidity of 0.9% saline. Anaesth Intens Care 2000; 28: 287-292 [Medline].
44. Rose DR. Clinical physiology of acid-base and electrolyte disorders. New York: McGraw-Hill; 1994. p. 9, 319.
45. Peters JP, Van Slyke DD. Quantitative clinical chemistry, Vol. 2. Ch. 12. Methods. Baltimore: Williams & Wilkins; 1932.
46.
Effros RM.
Endogenous airway acidification: implications for asthma
pathology.
Am J Respir Crit Care Med
2001;
163:
293-294
This article has been cited by other articles:
![]() |
R. M. Effros Evidence for Airway Acidity and Oxidative Stress in Exhaled Breath Condensates from Grain Workers Am. J. Respir. Crit. Care Med., June 15, 2009; 179(12): 1166 - 1166. [Full Text] [PDF] |
||||
![]() |
C. R. Esther Jr., G. Boysen, B. M. Olsen, L. B. Collins, A. J. Ghio, J. W. Swenberg, and R. C. Boucher Mass spectrometric analysis of biomarkers and dilution markers in exhaled breath condensate reveals elevated purines in asthma and cystic fibrosis Am J Physiol Lung Cell Mol Physiol, June 1, 2009; 296(6): L987 - L993. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Effros Exhaled breath condensates and COPD Eur. Respir. J., May 1, 2009; 33(5): 1238 - 1238. [Full Text] [PDF] |
||||
![]() |
C. Brindicci, K. Ito, O. Torre, P. J. Barnes, and S. A. Kharitonov Effects of Aminoguanidine, an Inhibitor of Inducible Nitric Oxide Synthase, on Nitric Oxide Production and Its Metabolites in Healthy Control Subjects, Healthy Smokers, and COPD Patients Chest, February 1, 2009; 135(2): 353 - 367. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-J. Cruz, S. Sanchez-Vidaurre, P.-V. Romero, F. Morell, and X. Munoz Impact Of Age on pH, 8-Isoprostane, and Nitrogen Oxides in Exhaled Breath Condensate Chest, February 1, 2009; 135(2): 462 - 467. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. de Laurentiis, D. Paris, D. Melck, M. Maniscalco, S. Marsico, G. Corso, A. Motta, and M. Sofia Metabonomic analysis of exhaled breath condensate in adults by nuclear magnetic resonance spectroscopy Eur. Respir. J., November 1, 2008; 32(5): 1175 - 1183. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. L. Borrill, K. Roy, and D. Singh Exhaled breath condensate biomarkers in COPD Eur. Respir. J., August 1, 2008; 32(2): 472 - 486. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Esther Jr, N. E. Alexis, M. L. Clas, E. R. Lazarowski, S. H. Donaldson, C. M. Pedrosa Ribeiro, C. G. Moore, S. D. Davis, and R. C. Boucher Extracellular purines are biomarkers of neutrophilic airway inflammation Eur. Respir. J., May 1, 2008; 31(5): 949 - 956. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Effros Metabolomics in Exhaled Breath Condensates Am. J. Respir. Crit. Care Med., January 15, 2008; 177(2): 236 - 236. [Full Text] [PDF] |
||||
![]() |
P. Montuschi Review: Analysis of exhaled breath condensate in respiratory medicine: methodological aspects and potential clinical applications Therapeutic Advances in Respiratory Disease, October 1, 2007; 1(1): 5 - 23. [Abstract] [PDF] |
||||
![]() |
E. H. Baker, N. Clark, A. L. Brennan, D. A. Fisher, K. M. Gyi, M. E. Hodson, B. J. Philips, D. L. Baines, and D. M. Wood Hyperglycemia and cystic fibrosis alter respiratory fluid glucose concentrations estimated by breath condensate analysis J Appl Physiol, May 1, 2007; 102(5): 1969 - 1975. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kodric, A. N. Shah, L. M. Fabbri, and M. Confalonieri An Investigation of Airway Acidification in Asthma Using Induced Sputum: A Study of Feasibility and Correlation Am. J. Respir. Crit. Care Med., May 1, 2007; 175(9): 905 - 910. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Jackson, A. Sandrini, C. Campbell, S. Chow, P. S. Thomas, and D. H. Yates Comparison of Biomarkers in Exhaled Breath Condensate and Bronchoalveolar Lavage Am. J. Respir. Crit. Care Med., February 1, 2007; 175(3): 222 - 227. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. G. Muller, F. Morini, S. Eaton, M. Peters, and A. Jaffe Safety and feasibility of exhaled breath condensate collection in ventilated infants and children Eur. Respir. J., September 1, 2006; 28(3): 479 - 485. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Effros Exhaled Breath Condensate pH. Am. J. Respir. Crit. Care Med., May 1, 2006; 173(9): 1047b - 11048. [Full Text] [PDF] |
||||
![]() |
R. M. Effros, R. Casaburi, J. Su, M. Dunning, J. Torday, J. Biller, and R. Shaker The Effects of Volatile Salivary Acids and Bases on Exhaled Breath Condensate pH Am. J. Respir. Crit. Care Med., February 15, 2006; 173(4): 386 - 392. [Abstract] [Full Text] [PDF] |
||||
![]() |
ATS Workshop Proceedings: Exhaled Nitric Oxide and Nitric Oxide Oxidative Metabolism in Exhaled Breath Condensate. Proceedings of the ATS, January 1, 2006; 3(2): 131 - 145. [Full Text] [PDF] |
||||
![]() |
S. Matalon and S. I. Rennard Thrombin Increases Lung Water by Decreasing Na,K-ATPase Activity Am. J. Respir. Cell Mol. Biol., October 1, 2005; 33(4): 317 - 318. [Full Text] [PDF] |
||||
![]() |
R. M. Effros, B. Peterson, R. Casaburi, J. Su, M. Dunning, J. Torday, J. Biller, and R. Shaker Epithelial lining fluid solute concentrations in chronic obstructive lung disease patients and normal subjects J Appl Physiol, October 1, 2005; 99(4): 1286 - 1292. [Abstract] [Full Text] [PDF] |
||||
![]() |
P Montuschi, F Macagno, P Parente, S Valente, L Lauriola, G Ciappi, S A Kharitonov, P J Barnes, and G Ciabattoni Effects of cyclo-oxygenase inhibition on exhaled eicosanoids in patients with COPD Thorax, October 1, 2005; 60(10): 827 - 833. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Holz Catching breath: monitoring airway inflammation using exhaled breath condensate Eur. Respir. J., September 1, 2005; 26(3): 371 - 372. [Full Text] [PDF] |
||||
![]() |
H Marteus, D C Tornberg, E Weitzberg, U Schedin, and K Alving Origin of nitrite and nitrate in nasal and exhaled breath condensate and relation to nitric oxide formation Thorax, March 1, 2005; 60(3): 219 - 225. [Abstract] [Full Text] [PDF] |
||||
![]() |
J C Ojoo, S A Mulrennan, J A Kastelik, A H Morice, and A E Redington Exhaled breath condensate pH and exhaled nitric oxide in allergic asthma and in cystic fibrosis Thorax, January 1, 2005; 60(1): 22 - 26. [Abstract] [Full Text] [PDF] |
||||
![]() |
K Wells, J Vaughan, T N Pajewski, S Hom, L Ngamtrakulpanit, A Smith, A Nguyen, R Turner, and J Hunt Exhaled breath condensate pH assays are not influenced by oral ammonia Thorax, January 1, 2005; 60(1): 27 - 31. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Corradi, P. Pignatti, P. Manini, R. Andreoli, M. Goldoni, M. Poppa, G. Moscato, B. Balbi, and A. Mutti Comparison between exhaled and sputum oxidative stress biomarkers in chronic airway inflammation Eur. Respir. J., December 1, 2004; 24(6): 1011 - 1017. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Effros, M. B. Dunning III, J. Biller, and R. Shaker The promise and perils of exhaled breath condensates Am J Physiol Lung Cell Mol Physiol, December 1, 2004; 287(6): L1073 - L1080. [Abstract] [Full Text] [PDF] |
||||
![]() |
J B McCafferty, T A Bradshaw, S Tate, A P Greening, and J A Innes Effects of breathing pattern and inspired air conditions on breath condensate volume, pH, nitrite, and protein concentrations Thorax, August 1, 2004; 59(8): 694 - 698. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. E. Carpagnano, P. J. Barnes, J. Francis, N. Wilson, A. Bush, and S. A. Kharitonov Breath Condensate pH in Children With Cystic Fibrosis and Asthma: A New Noninvasive Marker of Airway Inflammation? Chest, June 1, 2004; 125(6): 2005 - 2010. [Abstract] [Full Text] [PDF] |
||||
![]() |
P Cap, J Chladek, F Pehal, M Maly, V Petru, P J Barnes, and P Montuschi Gas chromatography/mass spectrometry analysis of exhaled leukotrienes in asthmatic patients Thorax, June 1, 2004; 59(6): 465 - 470. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Effros, J. Biller, B. Foss, K. Hoagland, M. B. Dunning, D. Castillo, M. Bosbous, F. Sun, and R. Shaker A Simple Method for Estimating Respiratory Solute Dilution in Exhaled Breath Condensates Am. J. Respir. Crit. Care Med., December 15, 2003; 168(12): 1500 - 1505. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Vaughan, L. Ngamtrakulpanit, T.N. Pajewski, R. Turner, T-A. Nguyen, A. Smith, P. Urban, S. Hom, B. Gaston, and J. Hunt Exhaled breath condensate pH is a robust and reproducible assay of airway acidity Eur. Respir. J., December 1, 2003; 22(6): 889 - 894. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Effros, B. Gaston, A. Mutti, and M. Corradi Saving the Breath Condensate Approach Am. J. Respir. Crit. Care Med., November 1, 2003; 168(9): 1129 - 1132. [Full Text] |
||||
![]() |
A. Mutti, M. Corradi, I. Rubinstein, and R. M. Effros Reporting Data on Exhaled Breath Condensate Am. J. Respir. Crit. Care Med., September 15, 2003; 168(6): 719 - 719. [Full Text] |
||||
![]() |
C. Wijkstrom-Frei, S. El-Chemaly, R. Ali-Rachedi, C. Gerson, M. A. Cobas, R. Forteza, M. Salathe, and G. E. Conner Lactoperoxidase and Human Airway Host Defense Am. J. Respir. Cell Mol. Biol., August 1, 2003; 29(2): 206 - 212. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Horvath Exhaled breath condensate contains more than only volatiles Eur. Respir. J., July 1, 2003; 22(1): 187 - 188. [Full Text] [PDF] |
||||
![]() |
E. Baraldi, L. Ghiro, V. Piovan, S. Carraro, G. Ciabattoni, P. J. Barnes, and P. Montuschi Increased Exhaled 8-Isoprostane in Childhood Asthma Chest, July 1, 2003; 124(1): 25 - 31. [Abstract] [Full Text] [PDF] |
||||
![]() |
P Montuschi, S A Kharitonov, G Ciabattoni, and P J Barnes Exhaled leukotrienes and prostaglandins in COPD Thorax, July 1, 2003; 58(7): 585 - 588. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Vass, E. Huszar, E. Barat, M. Valyon, D. Kiss, I. Penzes, M. Augusztinovicz, and I. Horvath Comparison of Nasal and Oral Inhalation during Exhaled Breath Condensate Collection Am. J. Respir. Crit. Care Med., March 15, 2003; 167(6): 850 - 855. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Zacharasiewicz, N. Wilson, A. Bush, and R. M. Effros Dilution of respiratory solutes in exhaled condensates Am. J. Respir. Crit. Care Med., March 1, 2003; 167(5): 802 - 802. [Full Text] |
||||
![]() |
B. Gaston Breath Condensate Analysis: Perhaps Worth Studying, After All Am. J. Respir. Crit. Care Med., February 1, 2003; 167(3): 292 - 293. [Full Text] [PDF] |
||||
![]() |
M. J. Tobin Asthma, Airway Biology, and Nasal Disorders in AJRCCM 2002 Am. J. Respir. Crit. Care Med., February 1, 2003; 167(3): 319 - 332. [Full Text] [PDF] |
||||
![]() |
M. Corradi, G. Folesani, R. Andreoli, P. Manini, A. Bodini, G. Piacentini, S. Carraro, S. Zanconato, and E. Baraldi Aldehydes and Glutathione in Exhaled Breath Condensate of Children with Asthma Exacerbation Am. J. Respir. Crit. Care Med., February 1, 2003; 167(3): 395 - 399. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Effros, B. M. Gaston, and J. F. Hunt Do low exhaled condensate nh4+ concentrations in asthma reflect reduced pulmonary production? Am. J. Respir. Crit. Care Med., January 1, 2003; 167(1): 91 - 92. [Full Text] |
||||
![]() |
Poster presentations Thorax, December 1, 2002; 57(90003): iii48 - 94. [Full Text] [PDF] |
||||
![]() |
B. Gaston and J. F. Hunt How Acidopneic Is My Patient? A New Question in the Pulmonary Laboratory Am. J. Respir. Crit. Care Med., May 15, 2002; 165(10): 1349 - 1350. [Full Text] [PDF] |
||||
![]() |
R. W. Hyde ""I Don't Know What You Guys Are Measuring But You Sure Are Measuring It!"" . A Fair Criticism of Measurements of Exhaled Condensates? Am. J. Respir. Crit. Care Med., March 1, 2002; 165(5): 561 - 562. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. | Am. J. Respir. Cell Mol. Biol. |